A unique form of polycythemia associated with minimal change disease.
OBJECTIVE
To present a case with nephrotic syndrome due to minimal change disease and polycythemia.


METHODS
A 20-year-old female was admitted to our clinic for edema and severe proteinuria present with minimal change disease since the age of 7 years. Polycythemia was found during the last activation of nephrotic syndrome. The patient was placed on glucocorticoid therapy that caused disappearance of edema, proteinuria and polycythemia. Ten months later both hemoglobin and hematocrit levels were within normal range.


CONCLUSIONS
This patient with nephrotic syndrome due to minimal change disease and polycythemia was successfully treated with glucocorticoid.
Balal
Mustafa
M
Department of Internal Medicine, Cukurova University Medical Faculty, Adana, Turkey.
Seyrek
Neslihan
N
Karayaylali
Ibrahim
I
Paydas
Saime
S
D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D004487:Edema / Q000188:drug therapy / Q000209:etiology; D005260:Female; D017328:Fosinopril / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008775:Methylprednisolone / Q000627:therapeutic use; D009402:Nephrosis, Lipoid / Q000150:complications* / Q000188:drug therapy; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011086:Polycythemia / Q000188:drug therapy / Q000209:etiology*; D011507:Proteinuria / Q000188:drug therapy / Q000209:etiology
D000806:Angiotensin-Converting Enzyme Inhibitors; D005938:Glucocorticoids; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin; D017328:Fosinopril; D008775:Methylprednisolone